Compagnie Lombard Odier SCmA Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$43.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$23M |
| 3 |
PVH
PVH
|
+$16.2M |
| 4 |
PX
Praxair Inc
PX
|
+$12.2M |
| 5 |
Merck
MRK
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$85.4M |
| 2 |
Amgen
AMGN
|
+$53.9M |
| 3 |
Visa
V
|
+$47.1M |
| 4 |
US Bancorp
USB
|
+$43.6M |
| 5 |
Apple
AAPL
|
+$27.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Consumer Staples | 14.1% |
| 3 | Financials | 11.08% |
| 4 | Energy | 9.61% |
| 5 | Technology | 9.14% |
Similar funds
Compagnie Lombard Odier SCmA's Q4 2014 Portfolio in Review
As of Q4 2014, Compagnie Lombard Odier SCmA held 929 positions worth $2.17B, down 12% from $2.48B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Compagnie Lombard Odier SCmA withdrew a net $332M in Q4 2014, closing 157 positions and reducing 370 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $9.59M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Compagnie Lombard Odier SCmA opened a new position in Patterson-UTI worth $5.11M.
- Compagnie Lombard Odier SCmA's largest Q4 2014 buy was Patterson-UTI: 308,000 shares worth $5.11M.
- Compagnie Lombard Odier SCmA added most to AbbVie in Q4 2014, an estimated $43.9M increase.
- Compagnie Lombard Odier SCmA's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $85.4M.
- Compagnie Lombard Odier SCmA fully exited Walgreens Boots Alliance in Q4 2014, selling an estimated $9.59M.
- Compagnie Lombard Odier SCmA's ten largest holdings make up 37% of its $2.17B portfolio in Q4 2014.
- Compagnie Lombard Odier SCmA opened 67 new positions and closed 157 in Q4 2014.
- Compagnie Lombard Odier SCmA's portfolio value fell 12% quarter-over-quarter to $2.17B.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2014, filed 13 Feb 2015.